The oxidation of sparteine

被引:5
|
作者
Willstatter, R
Marx, W
机构
来源
BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT | 1905年 / 38卷
关键词
D O I
10.1002/cber.19050380290
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:1772 / 1780
页数:9
相关论文
共 50 条
  • [21] THE RELATIONSHIP BETWEEN IMIPRAMINE METABOLISM AND THE SPARTEINE OXIDATION POLYMORPHISM
    BROSEN, K
    DANISH MEDICAL BULLETIN, 1988, 35 (05): : 460 - 468
  • [22] POLYMORPHISM IN SPARTEINE OXIDATION IN THE BARAKWENA (KWENGO) OF SOUTHERN AFRICA
    SOMMERS, D
    MONCRIEFF, J
    AVENANT, J
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1990, 86 (01) : 28 - 29
  • [23] IMIPRAMINE DEMETHYLATION AND HYDROXYLATION - IMPACT OF SPARTEINE OXIDATION PHENOTYPE
    BROSEN, K
    OTTON, SV
    GRAM, LF
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 115 - 115
  • [24] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
    EICHELBAUM, M
    BERTILSSON, L
    SAWE, J
    ZEKORN, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
  • [25] ENZYMATIC BASIS OF THE DEBRISOQUINE SPARTEINE TYPE POLYMORPHISM OF DRUG OXIDATION
    DAYER, P
    KRONBACH, T
    GUT, J
    OSIKOWSKAEVERS, B
    EICHELBAUM, M
    MEYER, UA
    EXPERIENTIA, 1985, 41 (06): : 819 - 819
  • [26] LACK OF RELATIONSHIP BETWEEN QUINIDINE PHARMACOKINETICS AND THE SPARTEINE OXIDATION POLYMORPHISM
    NIELSEN, F
    ROSHOLM, JU
    BROSEN, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (06) : 501 - 504
  • [27] PHARMACOKINETICS OF N-PROPYLAJMALINE IN RELATION TO POLYMORPHIC SPARTEINE OXIDATION
    ZEKORN, C
    ACHTERT, G
    HAUSLEITER, HJ
    MOON, CH
    EICHELBAUM, M
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (22): : 1180 - 1186
  • [28] STUDIES ON MICROBIAL TRANSFORMATION .26. MICROBIAL OXIDATION OF (-)-SPARTEINE
    FURUYA, K
    AIDA, K
    KOISO, Y
    OKUDA, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1973, 21 (01) : 231 - 234
  • [29] GENETICALLY-DETERMINED SPARTEINE OXIDATION POLYMORPHISM IN A POLISH POPULATION
    ORZECHOWSKAJUZWENKO, K
    PAWLIK, J
    NIEWINSKI, P
    MILEJSKI, P
    DEMBOWSKI, J
    TUREK, J
    GOZDZIK, A
    SWIEBODZKI, L
    HORA, Z
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (05) : 481 - 483
  • [30] SPARTEINE OXIDATION BY THE HUMAN-LIVER - ABSENCE OF INHIBITION BY MEPHENYTOIN
    JURIMA, M
    INABA, T
    KALOW, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) : 426 - 428